1. Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway that can be targeted for therapy. (December 2016) Authors: Shen, Y.; Park, C.S.; Suppipat, K.; Mistretta, T.A.; Puppi, M.; Horton, T.; Rabin, K.; Meijerink, J.; Lacorazza, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗